Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.